Search

Author/Creator de Sande, Luis Miguel

1. A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer. (3rd January 2021)

Authors:
Pignata, Sandro; Scambia, Giovanni; Villanucci, Alessandro; Naglieri, Emanuele; Ibarbia, Mikel Arruti; Brusa, Federica; Bourgeois, Hugues; Sorio, Roberto; Casado, Antonio; Reichert, Dietmar; Dopchie, Catherine; De Rivas, Beatriz; de Sande, Luis Miguel
Journal:
Oncologist
Issue:
Volume 26:Number 4(2021)
Page Start:
e658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P-184 Data from the Cetuximab-Docetaxel scheme in head and neck cancer in patients with intermediate general condition in daily clinical practice. (July 2021)

Authors:
Sanchez-Cousido, Luis Felipe; Sanchez, Angel Rodriguez; López-Flores, Mariana; Lopez-Gonzalez, Ana; Castañón-López, Carmen; Lozano, Amaya Lanz; Mangudo, Beatriz Nieto; Taín, Pilar Diz; de Sande, Luis Miguel; Garcia-Palomo, Andrés
Journal:
Oral oncology
Issue:
Volume 118(2021)Supplement
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search